507 related articles for article (PubMed ID: 33382360)
1. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
[TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
3. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
5. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
[TBL] [Abstract][Full Text] [Related]
6. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
7. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
8. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
[TBL] [Abstract][Full Text] [Related]
9. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
10. Recovery of the gut microbiome following fecal microbiota transplantation.
Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
[TBL] [Abstract][Full Text] [Related]
11. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
[TBL] [Abstract][Full Text] [Related]
12. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
[TBL] [Abstract][Full Text] [Related]
14. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
16. A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory
Monaghan TM; Duggal NA; Rosati E; Griffin R; Hughes J; Roach B; Yang DY; Wang C; Wong K; Saxinger L; Pučić-Baković M; Vučković F; Klicek F; Lauc G; Tighe P; Mullish BH; Blanco JM; McDonald JAK; Marchesi JR; Xue N; Dottorini T; Acharjee A; Franke A; Li Y; Wong GK; Polytarchou C; Yau TO; Christodoulou N; Hatziapostolou M; Wang M; Russell LA; Kao DH
Cells; 2021 Nov; 10(11):. PubMed ID: 34831456
[TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
18. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
[TBL] [Abstract][Full Text] [Related]
19. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation.
Smillie CS; Sauk J; Gevers D; Friedman J; Sung J; Youngster I; Hohmann EL; Staley C; Khoruts A; Sadowsky MJ; Allegretti JR; Smith MB; Xavier RJ; Alm EJ
Cell Host Microbe; 2018 Feb; 23(2):229-240.e5. PubMed ID: 29447696
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.
Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK
J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
